secwatch.observer — SEC 8-K summary
======================================

Issuer:     Entrada Therapeutics, Inc. (TRDA)
CIK:        0001689375
Form:       8-K
Filed at:   2026-05-18T22:32:23+00:00
Accession:  0001104659-26-063325
Event type: other_material
Sentiment:  neutral
Materiality: 0.10
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Entrada updates corporate presentation; no specific financial or pipeline details disclosed
--------------------------------------------------------------------------------

- Filing includes updated corporate presentation (Exhibit 99.1) for use in investor meetings.
- Presentation dated May 2026 was furnished under Regulation FD.
- No specific changes in financial guidance, pipeline milestones, or leadership disclosed in the filing excerpt.
- The full presentation content was not provided in the filing text available for analysis.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1689375/000110465926063325/0001104659-26-063325-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1689375/000110465926063325/tm2614944d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-26-063325

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer